Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidisha Singh

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 23, 2021
Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United StatesElissa Meites, Laura Stone, Raiza Amiling, et al.
Journal of the Pediatric Infectious Diseases Society|June 19, 2021
Juvenile-Onset Recurrent Respiratory Papillomatosis in the United States, Epidemiology and HPV Types-2015-2020Raiza Amiling, Elissa Meites, Troy D Querec, et al.
Database : the Journal of Biological Databases and Curation|April 21, 2020
RA-map: building a state-of-the-art interactive knowledge base for rheumatoid arthritisVidisha Singh, George D Kalliolias, Marek Ostaszewski, et al.
Sexually Transmitted Diseases|September 14, 2019
Transgender Women Have Higher Human Papillomavirus Prevalence Than Men Who Have Sex With Men-Two U.S. Cities, 2012-2014Vidisha Singh, Beau Gratzer, Pamina M Gorbach, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2016
Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralizationJordan R Willis, Jessica A Finn, Bryan Briney, et al.
Vaccine|July 11, 2016
Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessmentDavid K Clarke, R Michael Hendry, Vidisha Singh, et al.
Vaccine|December 1, 2018
Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccinesSonali Kochhar, Jean-Louis Excler, Karin Bok, et al.
The Journal of Infectious Diseases|February 3, 2026
Limited sex-based differences in viral outcomes of ART-treated SIV/SHIV infectionKedan Endrias, Soham Sonawane, Kirk A Easley, et al.
Nature Immunology|October 6, 2021
SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19Supriya Ravichandran, Juanjie Tang, Gabrielle Grubbs, et al.
JCI Insight|January 19, 2022
Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19Vidisha Singh, Veronica Obregon-Perko, Stacey A Lapp, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 23, 2021
Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United StatesElissa Meites, Laura Stone, Raiza Amiling, et al.
Journal of the Pediatric Infectious Diseases Society|June 19, 2021
Juvenile-Onset Recurrent Respiratory Papillomatosis in the United States, Epidemiology and HPV Types-2015-2020Raiza Amiling, Elissa Meites, Troy D Querec, et al.
Database : the Journal of Biological Databases and Curation|April 21, 2020
RA-map: building a state-of-the-art interactive knowledge base for rheumatoid arthritisVidisha Singh, George D Kalliolias, Marek Ostaszewski, et al.
Sexually Transmitted Diseases|September 14, 2019
Transgender Women Have Higher Human Papillomavirus Prevalence Than Men Who Have Sex With Men-Two U.S. Cities, 2012-2014Vidisha Singh, Beau Gratzer, Pamina M Gorbach, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2016
Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralizationJordan R Willis, Jessica A Finn, Bryan Briney, et al.
Vaccine|July 11, 2016
Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessmentDavid K Clarke, R Michael Hendry, Vidisha Singh, et al.
Vaccine|December 1, 2018
Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccinesSonali Kochhar, Jean-Louis Excler, Karin Bok, et al.
The Journal of Infectious Diseases|February 3, 2026
Limited sex-based differences in viral outcomes of ART-treated SIV/SHIV infectionKedan Endrias, Soham Sonawane, Kirk A Easley, et al.
Nature Immunology|October 6, 2021
SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19Supriya Ravichandran, Juanjie Tang, Gabrielle Grubbs, et al.
JCI Insight|January 19, 2022
Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19Vidisha Singh, Veronica Obregon-Perko, Stacey A Lapp, et al.
Pageof 4